Authors:
HEUREUX F
NISOLLE JF
DELGRANGE E
DONCKIER J
Citation: F. Heureux et al., DIABETIC MUSCLE INFARCTION - A DIFFICULT DIAGNOSIS SUGGESTED BY MAGNETIC-RESONANCE-IMAGING, Diabetic medicine, 15(7), 1998, pp. 621-622
Citation: E. Delgrange et al., LATE DEVELOPMENT OF RESISTANCE TO BROMOCRIPTINE IN A PATIENT WITH MACROPROLACTINOMA, Hormone research, 49(5), 1998, pp. 250-253
Citation: E. Delgrange et J. Donckier, GONADAL DYSFUNCTION IN MALES WITH PROLACTINOMA - FROM FUNCTIONAL MODIFICATION TO IRREVERSIBLE DAMAGE, European journal of endocrinology, 136(6), 1997, pp. 630-630
Citation: E. Delgrange et J. Donckier, PROLACTINOMAS APPARENTLY RESISTANT TO QUINAGOLIDE RESPOND TO CABERGOLINE THERAPY, The Journal of clinical endocrinology and metabolism, 82(8), 1997, pp. 2755-2756
Authors:
DELGRANGE E
TROUILLAS J
MAITER D
DONCKIER J
TOURNIAIRE J
Citation: E. Delgrange et al., SEX-RELATED DIFFERENCE IN THE GROWTH OF PROLACTINOMAS - A CLINICAL AND PROLIFERATION MARKER STUDY, The Journal of clinical endocrinology and metabolism, 82(7), 1997, pp. 2102-2107
Citation: E. Delgrange et al., EFFECTS OF THE DOPAMINE AGONIST CABERGOLINE IN PATIENTS WITH PROLACTINOMA INTOLERANT OR RESISTANT TO BROMOCRIPTINE, European journal of endocrinology, 134(4), 1996, pp. 454-456
Authors:
DELGRANGE E
GOETHALS P
LAKA A
MAITER D
LAMBERT M
Citation: E. Delgrange et al., AN UNUSUAL CASE OF BILATERAL VIRILIZING ADRENAL ADENOMA CO-SECRETING ANDROGENS AND CORTISOL, Journal of endocrinological investigation, 19(6), 1996, pp. 377-381
Authors:
DELGRANGE E
DEHERTOGH R
VANKRIEKEN L
MAITER D
Citation: E. Delgrange et al., POTENTIAL HOOK EFFECT IN PROLACTIN ASSAY IN PATIENTS WITH GIANT PROLACTINOMA, Clinical endocrinology, 45(4), 1996, pp. 506-506